Population pharmacokinetics of midazolam in neonates

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Clinical pharmacology and therapy

• Publication date

  1994-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/clpt.1994.186PMID 7995003
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Midazolam

  2012cited by this paper
• Pharmacokinetics of midazolam during continuous infusion in critically ill neonates

  2004cited by this paper
• The pharmacokinetics of midazolam in paediatric patients

  2004cited by this paper
• Pharmacokinetics of midazolam in critically ill neonates

  2004cited by this paper
• Analgesia and sedation in neonatal intensive care using fentanyl by continuous infusion.

  1993cited by this paper
• Comparison of the effect of midazolam or vecuronium on blood pressure and cerebral blood flow velocity in the premature newborn.

  1992cited by this paper
• The use of midazolam in the preterm neonate

  1992cited by this paper
• Building population pharmacokineticpharmacodynamic models. I. Models for covariate effects

  1992cited by this paper
• Population pharmacokinetics/dynamics.

  1992cited by this paper
• Clinical experience with continuous intravenous sedation using midazolam and fentanyl in the paediatric intensive care unit

  1991cited by this paper
• Hypotension with midazolam and fentanyl in the newborn.

  1991cited by this paper
• Alfentanil pharmacokinetics in preterm infants.

  1990cited by this paper
• Nonlinear mixed effects models for repeated measures data.

  1990cited by this paper
• Tolerance and dependence in neonates sedated with fentanyl during extracorporeal membrane oxygenation.

  1990cited by this paper
• A pharmacokinetic study of midazolam in paediatric patients undergoing cardiac surgery.

  1988cited by this paper
• Continuous intravenous midazolam infusion for sedation in the pediatric intensive care unit.

  1988cited by this paper
• Clinical pharmacokinetics of midazolam in intensive care patients, a wide interpatient variability?

  1988cited by this paper
• Randomised trial of fentanyl anaesthesia in preterm babies undergoing surgery: effects on the stress response.

  1987cited by this paper
• Randomized Trial of Fentanyl Anesthesia in Preterm Babies Undergoing Surgery: Effects on the Stress Response

  1987cited by this paper
• Clinical Pharmacokinetics of Long-Term Infusion of Midazolam in Critically Ill Patients — Preliminary Results

  1987cited by this paper
• Pain and its effects in the human neonate and fetus.

  1987cited by this paper
• Cerebral blood flow velocity variability in infants receiving assisted ventilation.

  1987cited by this paper
• Goodman and Gilman's The Pharmacological Basis of Therapeutics

  1986cited by this paper
• Pharmacokinetics of fentanyl

  1986cited by this paper
• Infusion of midazolam in paediatric patients after cardiac surgery.

  1986cited by this paper
• Sedation of children requiring artificial ventilation using an infusion of midazolam.

  1986cited by this paper
• Midazolam: The First Water‐soluble Benzodiazepine; Pharmacology, Pharmacokinetics and Efficacy in Insomnia and Anesthesia

  1985cited by this paper
• Reduction in intraventricular hemorrhage by elimination of fluctuating cerebral blood-flow velocity in preterm infants with respiratory distress syndrome.

  1985cited by this paper
• Determination of midazolam (Versed) and its metabolites in plasma by high-performance liquid chromatography.

  1985cited by this paper
• Pharmacokinetics of Fentanyl in Neonates

  1984cited by this paper
• Chemical structure and properties of midazolam compared with other benzodiazepines.

  1983cited by this paper
• Interaction of spontaneous respiration with artificial ventilation in preterm babies.

  1983cited by this paper
• Comparison of the effects of intravenously administered midazolam, triazolam and their hydroxy metabolites.

  1983cited by this paper
• Phenobarbital pharmacokinetics in neonates

  1978cited by this paper
• Diazepam elimination in premature and full term infants, and children

  1973cited by this paper

• Midazolam for sedation of infants in the neonatal intensive care unit.

  2025cites this paper
• Pharmacokinetic variability of antiepileptic drugs in neonates: A narrative review

  2025cites this paper
• Multicenter Population Pharmacokinetics of Fentanyl in Neonatal Surgical Patients Using Dried Blood Spot Specimen Collection Demonstrates Maturation of Elimination Clearance

  2024cites this paper
• Drug Disposition in Neonatal Göttingen Minipigs: Exploring Effects of Perinatal Asphyxia and Therapeutic Hypothermia

  2024cites this paper
• The Use of Midazolam as an Antiseizure Medication in Neonatal Seizures: Single Center Experience and Literature Review.

  2023cites this paper
• Intranasal Dexmedetomidine With Intravenous Midazolam: A Safe and Effective Alternative in the Paediatric MRI Sedation

  2023cites this paper
• Analgesia and sedation strategies in neonates undergoing whole-body therapeutic hypothermia: A scoping review

  2023cites this paper
• Ontogeny of CYP3A and UGT activity in preterm piglets: a translational model for drug metabolism in preterm newborns

  2023cites this paper
• Maraviroc Population Pharmacokinetics Within the First 6 Weeks of Life

  2022cites this paper
• The Blind Spot of Pharmacology: A Scoping Review of Drug Metabolism in Prematurely Born Children

  2022cites this paper
• Cerebral Oxygenation and Activity During Surgical Repair of Neonates With Congenital Diaphragmatic Hernia: A Center Comparison Analysis

  2021cites this paper
• Pharmacokinetics and Pharmacodynamics in the Pediatric Population

  2021cites this paper
• Schmerztherapie bei Kindern

  2021cites this paper
• Model‐Based Drug–Drug Interaction Extrapolation Strategy From Adults to Children: Risdiplam in Pediatric Patients With Spinal Muscular Atrophy

  2021cites this paper
• precision of pharmacokinetic parameters in children a systematic review

  2020cites this paper
• First dose in neonates: pharmacokinetic bridging study from juvenile mice to neonates for drugs metabolized by CYP3A

  2020cites this paper
• Electronic Health Record–Embedded Decision Support Platform for Morphine Precision Dosing in Neonates

  2020cites this paper
• Drugs for anaesthesia and analgesia in the preterm infant.

  2020cites this paper
• Pharmacokinetics and Pharmacology of Drugs Used in Children

  2019cites this paper
• Sedation for Diagnostic and Therapeutic Procedures Outside the Operating Room

  2019cites this paper
• Maturation of midazolam clearance in critically ill children with severe bronchiolitis: a population pharmacokinetic analysis.

  2019cites this paper
• Pharmacology of Common Analgesic and Sedative Drugs Used in the Neonatal Intensive Care Unit.

  2019cites this paper
• Pharmakokinetik bei Kindern: Worauf kommt es bei der korrekten Medikamentendosierung an?

  2019cites this paper
• Recently Registered Midazolam Doses for Preterm Neonates Do Not Lead to Equal Exposure: A Population Pharmacokinetic Model

  2019cites this paper
• Discontinuities and disruptions in drug dosage guidelines for the paediatric population

  2018cites this paper
• Essentials of Anesthesia for Infants and Neonates

  2018cites this paper
• Population pharmacokinetic evaluation of ADV6209, an innovative oral solution of midazolam containing cyclodextrin

  2018cites this paper
• Hepatic Drug Metabolism in Pediatric Patients

  2017cites this paper
• 18 – Basic Pharmacologic Principles

  2017cites this paper
• Predicting CYP3A‐mediated midazolam metabolism in critically ill neonates, infants, children and adults with inflammation and organ failure

  2017cites this paper
• Acute symptomatic neonatal seizures in preterm neonates: etiologies and treatments.

  2017cites this paper
• Age Variation when Coining Drugs as High vs Low Hepatic Extraction Ratio

  2016cites this paper
• Scaling clearance in paediatric pharmacokinetics: All models are wrong, which are useful?

  2016cites this paper
• Considering Age Variation When Coining Drugs as High versus Low Hepatic Extraction Ratio

  2016cites this paper
• Anesthesia and Ancillary Drugs and the Neonate

  2015cites this paper
• Anticonvulsant Effectiveness and Hemodynamic Safety of Midazolam in Full-Term Infants Treated with Hypothermia

  2015cites this paper
• Prediction of drug clearance in children: a review of different methodologies

  2015cites this paper
• Clinical Pharmacology of Midazolam in Neonates and Children: Effect of Disease—A Review

  2014cites this paper
• Neonatal pain control and neurologic effects of anesthetics and sedatives in preterm infants.

  2014cites this paper
• Inter-individual variation in midazolam clearance in children

  2014cites this paper
• Clinical pharmacology of analgesics in infants and the pharmacologic management of pain in neonates

  2014cites this paper
• APPLICATIONS OF PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELLING TO PREDICTION OF THE LIKELIHOOD OF METABOLIC DRUG INTERACTIONS IN PAEDIATRIC POPULATION AND STUDYING DISPARITIES IN PHARMACOKINETICS BETWEEN CHILDREN AND ADULTS

  2014cites this paper
• Using the caffeine breath test to study drug metabolism in protein-energy malnourished children

  2014cites this paper
• Clinical Pharmacology in Pediatrics

  2014cites this paper
• Pharmacokinetic studies in infants using minimal-risk study designs.

  2014cites this paper
• postnatal adaptation to orthostasis in swine Venous hydrostatic indifference point as a marker of

  2013cites this paper
• Erratum to: A Novel Maturation Function for Clearance of the Cytochrome P450 3A Substrate Midazolam from Preterm Neonates to Adults

  2013cites this paper
• Disposition of Midazolam in Asphyxiated Neonates Receiving Therapeutic Hypothermia – A Pilot Study

  2013cites this paper
• Novel approach to characterize developmental changes in pharmacokinetics across the human lifespan : application to the prediction of clearance in children

  2013cites this paper
• Thermopharmacology of anticonvulsive treatment after perinatal asphyxia

  2013cites this paper
• Developmental Changes in the Expression and Function of Cytochrome P450 3A Isoforms: Evidence from In Vitro and In Vivo Investigations

  2013cites this paper
• Maturation of cytochrome P450 3A mediated drug metabolism: Towards individualized dosing in children

  2013cites this paper
• Prediction of heptatic and renal clearance in pediatric populations: A "bottom-up" approach versus "top-down" recognition of covariates

  2013cites this paper
• Individual and population pharmacokinetic compartment analysis: a graphic procedure for quantification of predictive performance

  2013cites this paper
• Disposition of Midazolam in Asphyxiated Neonates Receiving Therapeutic Hypothermia - A Pilot Study Metabolismus von Midazolam bei therapeutischer Hypothermie von asphyktischen Neugeborenen - eine Pilotstudie

  2013cites this paper
• A Novel Maturation Function for Clearance of the Cytochrome P450 3A Substrate Midazolam from Preterm Neonates to Adults

  2013cites this paper
• Growing up with midazolam in the neonatal and pediatric intensive care.

  2012cites this paper
• Abnormal Movements of Japanese Infants following Treatment with Midazolam in a Neonatal Intensive Care Unit: Incidence and Risk Factors

  2012cites this paper
• Population Pharmacokinetic Analysis during the First 2 Years of Life

  2012cites this paper
• Remifentanil/midazolam versus fentanyl/midazolam for analgesia and sedation of mechanically ventilated neonates and young infants: a randomized controlled trial

  2012cites this paper
• Regulatory Experience With Physiologically Based Pharmacokinetic Modeling for Pediatric Drug Trials

  2012cites this paper
• Scaling of pharmacokinetics across paediatric populations: the lack of interpolative power of allometric models.

  2012cites this paper
• Sedation and analgesia in mechanically ventilated preterm neonates: continue standard of care or experiment?

  2012cites this paper
• Prediction of Cytochrome P450-Mediated Hepatic Drug Clearance in Neonates, Infants and Children

  2012cites this paper
• Innovative clinical trial design for pediatric therapeutics

  2011cites this paper
• Guidelines for the determination of brain death in infants and children: An update of the 1987 Task Force recommendations*

  2011cites this paper
• Profound changes in drug metabolism enzymes and possible effects on drug therapy in neonates and children

  2011cites this paper
• A maturation model for midazolam clearance

  2011cites this paper
• The effect of inflammation on drug metabolism: a focus on pediatrics.

  2011cites this paper
• 21 – Pharmacologic Adjuncts I

  2011cites this paper
• Pharmacology of Pediatric Anesthesia

  2011cites this paper
• Special Issues in Anesthesia for Pediatric Otolaryngology

  2011cites this paper
• Anesthésie-réanimation en chirurgie cardiaque du nouveau-né et du nourrisson

  2011cites this paper
• Clinical report—Guidelines for the determination of brain death in infants and children: an update of the 1987 task force recommendations.

  2011cites this paper
• Population Pharmacokinetics of Midazolam and Its Metabolites during Venoarterial Extracorporeal Membrane Oxygenation in Neonates

  2010cites this paper
• Blood concentrations of midazolam in status epilepticus using an appropriate condition of HPLC

  2010cites this paper
• Population Pharmacokinetics of Sildenafil in Term Neonates: Evidence of Rapid Maturation of Metabolic Clearance in the Early Postnatal Period

  2009cites this paper
• Sedation for Diagnostic and Therapeutic Procedures Outside the Operating Room

  2009cites this paper
• Challenges for drug studies in children: CYP3A phenotyping as example.

  2009cites this paper
• Facilitation of Drug Evaluation in Children by Population Methods and Modelling

  2008cites this paper
• Avaliação da percepção de dor em neonatos pré-termo sob sedo-analgesia

  2008cites this paper
• Pharmacokinetics and clinical efficacy of midazolam in children with severe malaria and convulsions

  2008cites this paper
• Intestinal Metabolism and Transport of Drugs in Children: The Effects of Age and Disease

  2008cites this paper
• Pharmacokinetics and clinical efficacy of lorazepam in children with severe malaria and convulsions.

  2008cites this paper
• Sedative Hypnotic and Anesthetic Agents: Their Effect on the Heart

  2008cites this paper
• DRUG MILK TO SERUM RATIO PREDICTION AND ONTOGENY OF CYP3A CLEARANCE PATHWAY AS A MODEL OF DRUG EXPOSURE IN THE DEVELOPING RAT

  2007cites this paper
• Benzodiazepines for Sedation in Infants and Children

  2006cites this paper
• Effects of Midazolam and Morphine on Cerebral Oxygenation and Hemodynamics in Ventilated Premature Infants

  2006cites this paper
• Chapter 6 – Pharmacology of Pediatric Anesthesia

  2006cites this paper
• Analgesia and anesthesia for neonates: study design and ethical issues.

  2005cites this paper
• Analgesia and local anesthesia during invasive procedures in the neonate.

  2005cites this paper
• Minimum effective dose of midazolam for sedation of mechanically ventilated neonates

  2005cites this paper
• Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling: theophylline and midazolam as model drugs.

  2005cites this paper
• Status Epilepticus: Clinical Analysis of a Treatment Protocol Based on Midazolam and Phenytoin

  2005cites this paper
• Status Epilepticus: Clinical Analysis of a Treatment Protocol Based on Midazolam and Phenytoin

  2005cites this paper
• Ontogeny of drug metabolizing enzymes in the neonate.

  2005cites this paper
• Analgesia and sedation during mechanical ventilation in neonates.

  2005cites this paper
• Anestesia y reanimación en la cirugía cardíaca del recién nacido y del lactante

  2004cites this paper
• Neonatal Exposure to Drugs in Breast Milk

  2004cites this paper
• Anesthésie-réanimation en chirurgie cardiaque du nouveau-né et du nourrisson

  2004cites this paper